SCHEMBL5606136

SCHEMBL5606136

CC(=O)c1cc2cc(Nc3c(-c4ccccc4)sn(C)c3=O)ccc2o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 3/20 0.43
GAA P10253 3/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 1/20 0.43
GLA P06280 1/20 0.43
CASP1 P29466 1/20 0.43
BRCA1 P38398 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
IKBKB O14920 1/20 0.38
NPC1 O15118 6/20 0.37
RAB9A P51151 6/20 0.37
P2RX3 P56373 2/20 0.37
SYK P43405 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 1/20 0.36
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607313 0.86 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL3487663 0.73 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL4692190 0.70 NR1H2 (0.45) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL3487918 0.69 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL11687990 0.69 GAA (0.61) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL3487585 0.69 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL4478931 0.68 ASAH1 (0.35) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL5607055 0.63 DGAT1 (0.48) SMN1; SMN2KDM4EGAALMNAHSD17B10
SCHEMBL1390692 0.63 KDM4E (1.00) SMN1; SMN2ALDH1A1KDM4EGAAHPGD
SCHEMBL30402838 0.63 KDM4E (1.00) SMN1; SMN2ALDH1A1KDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838686-A1 DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006073363-A1 DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO disclosed